Perrigo Company plc
Revenue Breakdown
| Fiscal Year | Consumer Self-Care Americas (CSCA) | Consumer Self-Care International (CSCI) | Consumer Healthcare Americas (CHCA) | Consumer Healthcare International (CHCI) | Consumer Healthcare (CHC) | Nutritionals | Rx Pharmaceuticals | Active Pharmaceutical Ingredients (API) | Specialty Sciences | Other |
|---|---|---|---|---|---|---|---|---|---|---|
| FY2006 | $0 | $0 | $0 | $0 | $1.02B | $0 | $192.1M | $162.7M | $0 | $41.5M |
| FY2007 | $0 | $0 | $0 | $0 | $1.10B | $0 | $179.6M | $164.5M | $0 | $35.7M |
| FY2008 | $0 | $0 | $0 | $0 | $1.35B | $0 | $232.0M | $182.2M | $0 | $41.8M |
| FY2009 | $0 | $0 | $0 | $0 | $1.57B | $0 | $241.9M | $148.9M | $0 | $52.8M |
| FY2010 | $0 | $0 | $0 | $0 | $1.76B | $89.9M | $286.9M | $140.6M | $0 | $0 |
| FY2011 | $0 | $0 | $0 | $0 | $1.88B | $450.8M | $303.4M | $124.3M | $0 | $0 |
| FY2012 | $0 | $0 | $0 | $0 | $1.97B | $500.0M | $511.4M | $151.7M | $39.3M | $0 |
| FY2013 | $0 | $0 | $0 | $0 | $2.13B | $516.3M | $701.3M | $149.2M | $48.4M | $0 |
| FY2014 | $0 | $0 | $0 | $0 | $2.24B | $526.4M | $854.2M | $137.5M | $300.0M | $0 |
| FY2015 | $0 | $0 | $0 | $0 | $2.28B | $553.8M | $1.01B | $138.8M | $608.5M | $0 |
| FY2016 | $0 | $0 | $2.49B | $1.62B | $0 | $0 | $1.06B | $0 | $114.7M | $0 |
| FY2017 | $0 | $0 | $2.43B | $1.53B | $0 | $0 | $950.4M | $0 | $21.5M | $0 |
| FY2018 | $0 | $0 | $2.43B | $1.41B | $0 | $0 | $896.7M | $0 | $0 | $0 |
| FY2019 | $2.67B | $1.37B | $0 | $0 | $0 | $0 | $1.02B | $0 | $0 | $0 |
| FY2020 | $2.75B | $1.38B | $0 | $0 | $0 | $0 | $927.4M | $0 | $0 | $0 |
| FY2021 | $2.69B | $1.44B | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| FY2022 | $2.79B | $1.66B | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| FY2023 | $2.93B | $1.73B | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |